The Réjuve medical device quickly increases fiber bonds in the tissue matrix to provide a mechanically stronger long-lasting tear-resistant tissue. Thus, it could become a replacement or adjunct to common surgical procedures such as discectomies, spinal fusions, and spinal implants.
Réjuve is an injectable crosslinking device that mechanically strengthens and quickly stabilizes the disc. This micro-invasive procedure can be performed on an outpatient basis and should be complete with just one injection treatment.
Introducing Réjuve- Your Spine Rejuvenated
The Réjuve medical device is designed to be effective in treating large avascular (no direct blood supply) load-supporting tissues like the spinal disc.
A key to Réjuve's effectiveness is the device's ability to promote crosslinking of fibrous proteins including collagen, which rejuvenates the spinal disk area.
Disc degeneration is happening to all of us; for most of us it can cause pain!
Annulus tissue becomes delaminated, fissured, or micro-damaged
Spinal joint becomes unstable
Disc bulges against nerves
Réjuve medical device reduces pain by:
Strengthening annulus against tearing and delamination
Increasing joint stability
Reducing disc bulge
Réjuve: Effectively Protected
There are twenty-five (25) issued patents to date with additional under review. Réjuve is also supported by thirty-two (32) peer-reviewed papers.
Intralink-Spine, Inc. has received ISO 13485:2016 certification for its Quality Management System (QMS) following review by its notified body, MedCert GmbH. ISO 13485:2016 is an internationally recognized quality standard specific to the medical device industry and signifies Intralink-Spine’s commitment to the highest level of medical device quality controls and meeting customer and international regulatory expectations.